Atlas Trials

Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus

Clinical trial NCT06616961 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06616961
Sponsor
Popular Medical College Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
ObesityType 2 Diabetes Mellitus (T2DM)
Start date
2024-11-01
Primary completion
2025-02-01
Enrollment
480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.